CytoSorbents flags new CytoSorb clinical data presentations at EACTS, ESICM conferences
CTSO•CytoSorbents said clinical data on its CytoSorb blood purification device are scheduled for presentation at EACTS and ESICM conferences in October 2026; results have not yet been presented.
1. Presentations scheduled
The scheduled talks will cover cardiac surgery bleeding risk, post-surgery shock, ECMO-related inflammation, sepsis and ARDS. They are set to highlight real-world registry experience from the COSMOS Registry, with outcomes framed around management of hyperinflammation and organ dysfunction in critical illness.
